Abnormal behavior
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
910
|
121
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Adolescent idiopathic scoliosis
|
disease |
Musculoskeletal Diseases
|
Anatomical Abnormality
|
656
|
1178
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Adverse effects, not elsewhere classified
|
disease |
|
Injury or Poisoning
|
55
|
54
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Alzheimer's Disease
|
disease |
Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
3397
|
1843
|
0.020 |
None |
1.000 |
2 |
|
2015 |
2019 |
Amphetamine Abuse
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
75
|
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Amphetamine Addiction
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
81
|
2
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Amphetamine-Related Disorders
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
78
|
3
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Attention deficit hyperactivity disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
842
|
420
|
0.130 |
None |
0.750 |
4 |
2
|
2008 |
2016 |
Autism Spectrum Disorders
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1071
|
331
|
0.020 |
None |
1.000 |
2 |
|
2009 |
2011 |
Autistic Disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1112
|
395
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Bardet-Biedl Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases; Nervous System Diseases
|
Disease or Syndrome
|
86
|
163
|
0.100 |
None |
1.000 |
4 |
3
|
2002 |
2013 |
BARDET-BIEDL SYNDROME 11
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases; Nervous System Diseases
|
Disease or Syndrome
|
5
|
2
|
0.100 |
None |
|
0 |
2
|
|
|
Bipolar Disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1183
|
839
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Body Height
|
phenotype |
|
Organism Attribute
|
1903
|
3972
|
0.100 |
None |
1.000 |
2 |
3
|
2019 |
2019 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.100 |
None |
1.000 |
1 |
2
|
2017 |
2017 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Chemical and Drug Induced Liver Injury
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
461
|
38
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Chronic Obstructive Airway Disease
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
1428
|
852
|
0.100 |
None |
1.000 |
2 |
2
|
2011 |
2019 |
Cognition Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
607
|
47
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Common Migraine
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
77
|
62
|
0.410 |
None |
1.000 |
4 |
1
|
2012 |
2017 |
Creatine phosphokinase serum increased
|
phenotype |
|
Finding
|
228
|
43
|
0.100 |
None |
|
0 |
1
|
|
|
Creatinine measurement, serum (procedure)
|
phenotype |
|
Laboratory Procedure
|
124
|
243
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Dementia
|
disease |
Nervous System Diseases; Mental Disorders
|
Mental or Behavioral Dysfunction
|
816
|
176
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Depressed bipolar I disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
37
|
59
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Diastolic blood pressure
|
phenotype |
|
Clinical Attribute
|
507
|
1037
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |